Itron initiated with a Neutral at Guggenheim

Guggenheim analyst Joseph Osha initiated coverage of Itron with a Neutral rating and no price target. While the firm sees the company having “some exciting market opportunities,” it also thinks that those prospects are reflected in the company’s current valuation, adding that the company’s “mixed track record factors into our valuation analysis.” There is room for upside if the company can improve its execution, the analyst tells investors.